These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 34179737)

  • 1. Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis.
    Crafa A; Cannarella R; Condorelli RA; Mongioì LM; Barbagallo F; Aversa A; La Vignera S; Calogero AE
    EClinicalMedicine; 2021 Jul; 37():100967. PubMed ID: 34179737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Vitamin D Status with SARS-CoV-2 Infection or COVID-19 Severity: A Systematic Review and Meta-analysis.
    Kazemi A; Mohammadi V; Aghababaee SK; Golzarand M; Clark CCT; Babajafari S
    Adv Nutr; 2021 Oct; 12(5):1636-1658. PubMed ID: 33751020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Vitamin D Level on COVID-19 Infection: Systematic Review and Meta-Analysis.
    Teshome A; Adane A; Girma B; Mekonnen ZA
    Front Public Health; 2021; 9():624559. PubMed ID: 33748066
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe vitamin D deficiency is not related to SARS-CoV-2 infection but may increase mortality risk in hospitalized adults: a retrospective case-control study in an Arab Gulf country.
    Alguwaihes AM; Sabico S; Hasanato R; Al-Sofiani ME; Megdad M; Albader SS; Alsari MH; Alelayan A; Alyusuf EY; Alzahrani SH; Al-Daghri NM; Jammah AA
    Aging Clin Exp Res; 2021 May; 33(5):1415-1422. PubMed ID: 33788172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D supplementation for the treatment of COVID-19: a living systematic review.
    Stroehlein JK; Wallqvist J; Iannizzi C; Mikolajewska A; Metzendorf MI; Benstoem C; Meybohm P; Becker M; Skoetz N; Stegemann M; Piechotta V
    Cochrane Database Syst Rev; 2021 May; 5(5):CD015043. PubMed ID: 34029377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and meta-analysis of effect of vitamin D levels on the incidence of COVID-19.
    Szarpak L; Rafique Z; Gasecka A; Chirico F; Gawel W; Hernik J; Kaminska H; Filipiak KJ; Jaguszewski MJ; Szarpak L
    Cardiol J; 2021; 28(5):647-654. PubMed ID: 34308537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of vitamin D deficiency on COVID-19: a systematic review and meta-analysis of observational studies.
    Kaya MO; Pamukçu E; Yakar B
    Epidemiol Health; 2021; 43():e2021074. PubMed ID: 34607398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study).
    Rastogi A; Bhansali A; Khare N; Suri V; Yaddanapudi N; Sachdeva N; Puri GD; Malhotra P
    Postgrad Med J; 2022 Feb; 98(1156):87-90. PubMed ID: 33184146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Serum Vitamin D Level Affect COVID-19 Infection and Its Severity?-A Case-Control Study.
    Ye K; Tang F; Liao X; Shaw BA; Deng M; Huang G; Qin Z; Peng X; Xiao H; Chen C; Liu X; Ning L; Wang B; Tang N; Li M; Xu F; Lin S; Yang J
    J Am Coll Nutr; 2021; 40(8):724-731. PubMed ID: 33048028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between the severity and mortality of SARS-CoV-2 infection and 25-hydroxyvitamin D concentration - a metaanalysis.
    Oscanoa TJ; Amado J; Vidal X; Laird E; Ghashut RA; Romero-Ortuno R
    Adv Respir Med; 2021; 89(2):145-157. PubMed ID: 33966262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes.
    Chiodini I; Gatti D; Soranna D; Merlotti D; Mingiano C; Fassio A; Adami G; Falchetti A; Eller-Vainicher C; Rossini M; Persani L; Zambon A; Gennari L
    Front Public Health; 2021; 9():736665. PubMed ID: 35004568
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of vitamin D against COVID-19 infection, progression and severity.
    Ahmed HS; Ahmed HS; Abud HN
    Hum Antibodies; 2024; 32(2):51-60. PubMed ID: 38640148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D Deficiency Is Associated With Higher Hospitalization Risk From COVID-19: A Retrospective Case-control Study.
    Jude EB; Ling SF; Allcock R; Yeap BXY; Pappachan JM
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4708-e4715. PubMed ID: 34139758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and Therapeutic Role of Vitamin D in COVID-19: Systematic Review and Meta-analysis.
    Dissanayake HA; de Silva NL; Sumanatilleke M; de Silva SDN; Gamage KKK; Dematapitiya C; Kuruppu DC; Ranasinghe P; Pathmanathan S; Katulanda P
    J Clin Endocrinol Metab; 2022 Apr; 107(5):1484-1502. PubMed ID: 34894254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial.
    Annweiler C; Beaudenon M; Gautier J; Gonsard J; Boucher S; Chapelet G; Darsonval A; Fougère B; Guérin O; Houvet M; Ménager P; Roubaud-Baudron C; Tchalla A; Souberbielle JC; Riou J; Parot-Schinkel E; Célarier T;
    PLoS Med; 2022 May; 19(5):e1003999. PubMed ID: 35639792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of vitamin D status on hospital length of stay and prognosis in hospitalized patients with moderate to severe COVID-19: a multicenter prospective cohort study.
    Reis BZ; Fernandes AL; Sales LP; Santos MD; Dos Santos CC; Pinto AJ; Goessler KF; Franco AS; Duran CSC; Silva CBR; Macêdo MB; Dalmolin HHH; Baggio J; Balbi GGM; Antonangelo L; Caparbo VF; Gualano B; Murai IH; Pereira RMR
    Am J Clin Nutr; 2021 Aug; 114(2):598-604. PubMed ID: 34020451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between predicted vitamin D status, vitamin D intake, and risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) severity.
    Ma W; Nguyen LH; Yue Y; Ding M; Drew DA; Wang K; Merino J; Rich-Edwards JW; Sun Q; Camargo CA; Giovannucci E; Willett W; Manson JE; Song M; Bhupathiraju SN; Chan AT
    Am J Clin Nutr; 2022 Apr; 115(4):1123-1133. PubMed ID: 34864844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.